1. Presented By Amrita Krishnan at 2016 ASCO Annual Meeting
Phase I/II Trial: <br />Ixazomib, Pomalidomide, Dexamethasone in Relapsed/Refractory Multiple Myeloma <br />Initial Results<br />
Presented By Amrita Krishnan at 2016 ASCO Annual Meeting

2. Presented By Amrita Krishnan at 2016 ASCO Annual Meeting
Background
Presented By Amrita Krishnan at 2016 ASCO Annual Meeting

3. Presented By Amrita Krishnan at 2016 ASCO Annual Meeting
Background
Presented By Amrita Krishnan at 2016 ASCO Annual Meeting

4. Presented By Amrita Krishnan at 2016 ASCO Annual Meeting
Methods
Presented By Amrita Krishnan at 2016 ASCO Annual Meeting

5. Presented By Amrita Krishnan at 2016 ASCO Annual Meeting
Slide 5
Presented By Amrita Krishnan at 2016 ASCO Annual Meeting

6. Presented By Amrita Krishnan at 2016 ASCO Annual Meeting
Slide 6
Presented By Amrita Krishnan at 2016 ASCO Annual Meeting

7. Presented By Amrita Krishnan at 2016 ASCO Annual Meeting
Slide 7
Presented By Amrita Krishnan at 2016 ASCO Annual Meeting

8. Presented By Amrita Krishnan at 2016 ASCO Annual Meeting
Adverse events
Presented By Amrita Krishnan at 2016 ASCO Annual Meeting

9. Dose-limiting toxicities
Presented By Amrita Krishnan at 2016 ASCO Annual Meeting

10. Presented By Amrita Krishnan at 2016 ASCO Annual Meeting
Conclusions
Presented By Amrita Krishnan at 2016 ASCO Annual Meeting

11. Presented By Amrita Krishnan at 2016 ASCO Annual Meeting
Acknowledgments
Presented By Amrita Krishnan at 2016 ASCO Annual Meeting

12. Presented By Amrita Krishnan at 2016 ASCO Annual Meeting
Acknowledgments
Presented By Amrita Krishnan at 2016 ASCO Annual Meeting

13. Presented By Amrita Krishnan at 2016 ASCO Annual Meeting
Slide 13
Presented By Amrita Krishnan at 2016 ASCO Annual Meeting

14. Presented By Amrita Krishnan at 2016 ASCO Annual Meeting
DLT definition
Presented By Amrita Krishnan at 2016 ASCO Annual Meeting

15. Presented By Amrita Krishnan at 2016 ASCO Annual Meeting
DLT definition
Presented By Amrita Krishnan at 2016 ASCO Annual Meeting